The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 435.40
Bid: 434.20
Ask: 434.60
Change: 14.40 (3.42%)
Spread: 0.40 (0.092%)
Open: 426.00
High: 437.20
Low: 426.00
Prev. Close: 421.00
STJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 AGM General Meeting Voting Results Update

15 Nov 2023 07:00

RNS Number : 4506T
St. James's Place PLC
15 November 2023
 

St. James's Place plc ('the Company')

2023 Annual General Meeting Voting Results - Update Statement

 

 

At the Company's Annual General Meeting ("AGM") held on 18 May 2023, 77.85% votes were cast in favour of Resolution 4, the advisory vote to approve the Directors' Remuneration Report for the year ended 31 December 2022 ("Resolution 4"). In accordance with provision 4 of the UK Corporate Governance Code this statement provides an update on the views received from shareholders and actions taken following a vote of 20% or more against an AGM resolution.

 

The Remuneration Committee ("Committee") engaged with shareholders, both in preparation for, and shortly after the AGM and was pleased to note that most shareholders supported Resolution 4 which was evident from the voting outcome. Specific feedback has also been sought from the minority of shareholders who voted against Resolution 4.

 

The small amount of feedback received related to the vesting outcome on the 2020 Performance Share Plan ("PSP") grant. This minority of shareholders said that they felt that the Committee should have applied a discretionary downward adjustment to the performance-based vesting outcome to take account of the fall in share price at the time of grant in 2020 and the effect of this on the number of shares granted. Also, they felt that the explanation provided in the Remuneration Report could have been enhanced to assist shareholders' assessment of the vesting outcome decided by the Committee. 

The Committee had provided an explanation in the Remuneration Report of the reasons for not applying a downward adjustment, including that the Committee had already exercised discretion to award zero annual bonuses for 2020 and to hold the 2020 PSP grants at the same percentage of salary as in 2019 rather than the higher level approved in the 2020 Policy vote. Applying a reduction to the vesting outcome in addition to the restraint already referred to above, risked damaging the credibility of the PSP also bearing in mind that no reciprocal upward adjustment could have been made in a previous year when the share price had 'spiked' at the time of grant resulting in a reduced number of shares being awarded.

 

The Committee is grateful for the feedback received from those shareholders who responded. The Committee's view is that it acted in the best interests of the Company and its stakeholders in not applying a downward adjustment to the performance-based vesting outcome. However, the Committee will keep in mind the views expressed by shareholders on this issue and will consider prior to grant whether any adjustment to the grant size of awards should be made and will aim to improve its communication in this regard.

 

The Board will continue to engage with shareholders and their representative bodies in line with our normal practice and will reflect their feedback, as appropriate in the 2023 Directors' Remuneration Report.

 

END

For further information, please contact:

Hugh Taylor, Director - Investor Relations

Tel: 07818 075143

Jamie Dunkley, External Communications Director

Tel: 07779 999651

? ?Brunswick Group

? ?Eilis Murphy

? ?Charles Pretzlik

Tel: 020 7404 5959

Email: sjp@brunswickgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFEFWLEDSEEF
Date   Source Headline
24th Apr 20244:10 pmRNSHolding(s) in Company
16th Apr 202411:08 amRNSHolding(s) in Company
9th Apr 20245:07 pmRNSNotice of AGM
2nd Apr 202410:11 amRNSTotal Voting Rights
26th Mar 202411:16 amRNSDirector/PDMR Shareholding
22nd Mar 202410:48 amRNSDirectorate Change
20th Mar 20243:52 pmRNSHolding(s) in Company
19th Mar 20241:44 pmRNSHolding(s) in Company
7th Mar 20244:29 pmRNSAnnual Report and Accounts 2023
1st Mar 20249:30 amRNSTotal Voting Rights
29th Feb 202410:52 amRNSHolding(s) in Company
28th Feb 20247:49 amRNSFinal Results - Re-Release
28th Feb 20247:00 amRNSFinal Results
1st Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20249:29 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSBlock listing Interim Review
31st Jan 20241:43 pmRNSDirectorate Change
25th Jan 20247:00 amRNS2023 New Business Inflows & Funds Under Management
2nd Jan 202410:44 amRNSTotal Voting Rights
22nd Dec 202311:13 amRNSHolding(s) in Company
20th Dec 202310:38 amRNSHolding(s) in Company
1st Dec 20231:43 pmRNSTotal Voting Rights
1st Dec 20238:51 amRNSCEO Succession Update
15th Nov 20237:00 amRNS2023 AGM General Meeting Voting Results Update
9th Nov 202312:27 pmRNSDirector Update
1st Nov 20234:10 pmRNSTotal Voting Rights
27th Oct 20234:17 pmRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20233:37 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSQ3 New Business Inflows and Funds Under Management
17th Oct 20237:00 amRNSSJP SIMPLIFIES CLIENT CHARGING MODELS
13th Oct 20234:11 pmRNSHolding(s) in Company
13th Oct 20237:00 amRNSResponse to Media Speculation
2nd Oct 202311:04 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 20237:04 amRNSCEO Succession
1st Sep 20231:10 pmRNSTotal Voting Rights
22nd Aug 20239:43 amRNSHolding(s) in Company
11th Aug 20234:30 pmRNSHolding(s) in Company
1st Aug 202311:40 amRNSBlock listing Interim Review
1st Aug 202310:44 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSHalf-year Report
3rd Jul 20239:58 amRNSTotal Voting Rights
27th Jun 20233:04 pmRNSHolding(s) in Company
2nd Jun 20232:53 pmRNSDirector/PDMR Shareholding
1st Jun 20239:13 amRNSTotal Voting Rights
23rd May 20232:59 pmRNSDirector/PDMR Shareholding
18th May 20231:20 pmRNSResult of AGM
4th May 20232:17 pmRNSDirector/PDMR Shareholding
3rd May 202310:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.